Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Debt (2017 - 2019)

AC Immune (ACIU) has disclosed Total Debt for 3 consecutive years, with $658770.1 as the latest value for Q4 2019.

  • On a quarterly basis, Total Debt rose 26.56% to $658770.1 in Q4 2019 year-over-year; TTM through Dec 2019 was $658770.1, a 26.56% increase, with the full-year FY2019 number at $656409.3, up 23.91% from a year prior.
  • Total Debt was $658770.1 for Q4 2019 at AC Immune, up from $520504.4 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $658770.1 in Q4 2019 to a low of $500708.2 in Q4 2017.
  • A 3-year average of $559994.2 and a median of $520504.4 in 2018 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: grew 3.95% in 2018, then grew 26.56% in 2019.
  • AC Immune's Total Debt stood at $500708.2 in 2017, then grew by 3.95% to $520504.4 in 2018, then rose by 26.56% to $658770.1 in 2019.
  • Per Business Quant, the three most recent readings for ACIU's Total Debt are $658770.1 (Q4 2019), $520504.4 (Q4 2018), and $500708.2 (Q4 2017).